For this study, Jabri and colleagues combined insights and data from celiac disease patients who had been cared for at the University of Chicago's Celiac Disease Center with experiments using a mouse
model of the disease developed in her lab.
Not exact matches
Of note, our models may underestimate the true maternal costs of suboptimal breastfeeding; we modeled the effects of lactation on only five maternal health conditions despite data linking lactation with other maternal health outcomes.46 In addition, women in our model could not develop type 2 diabetes mellitus, hypertension, or MI before age 35 years, although these conditions are becoming increasingly prevalent among young adults.47 Although some studies have found an association between lactation and rates of postmenopausal diabetes22, 23 and cardiovascular disease, 10 we conservatively limited the duration of lactation's effect on both diabetes and M
Of note, our
models may underestimate the true maternal costs
of suboptimal breastfeeding; we modeled the effects of lactation on only five maternal health conditions despite data linking lactation with other maternal health outcomes.46 In addition, women in our model could not develop type 2 diabetes mellitus, hypertension, or MI before age 35 years, although these conditions are becoming increasingly prevalent among young adults.47 Although some studies have found an association between lactation and rates of postmenopausal diabetes22, 23 and cardiovascular disease, 10 we conservatively limited the duration of lactation's effect on both diabetes and M
of suboptimal breastfeeding; we
modeled the effects
of lactation on only five maternal health conditions despite data linking lactation with other maternal health outcomes.46 In addition, women in our model could not develop type 2 diabetes mellitus, hypertension, or MI before age 35 years, although these conditions are becoming increasingly prevalent among young adults.47 Although some studies have found an association between lactation and rates of postmenopausal diabetes22, 23 and cardiovascular disease, 10 we conservatively limited the duration of lactation's effect on both diabetes and M
of lactation on only five maternal health conditions despite data linking lactation with other maternal health outcomes.46 In addition, women in our
model could not
develop type 2 diabetes mellitus, hypertension, or MI before age 35 years, although these conditions are becoming increasingly prevalent among young adults.47 Although some studies have found an association between lactation and rates
of postmenopausal diabetes22, 23 and cardiovascular disease, 10 we conservatively limited the duration of lactation's effect on both diabetes and M
of postmenopausal diabetes22, 23 and cardiovascular
disease, 10 we conservatively limited the duration
of lactation's effect on both diabetes and M
of lactation's effect on both diabetes and MI.
And researchers have
developed a wide range
of sophisticated computer
models that simulate human biology and the progression
of developing diseases.
Medicines that are personally tailored to your DNA are becoming a reality, thanks to the work
of U.S. and Chinese scientists who
developed statistical
models to predict which drug is best for a specific individual with a specific
disease.
Benjamin «Benjy» Firester, 18,
of New York City, won the top award
of $ 250,000 for
developing a mathematical
model that uses
disease data to predict how weather patterns could spread spores
of late blight fungus, which caused the Irish Potato Famine.
The company provides porcine
models of particular
diseases,
models that are used to
develop gene - based treatments and drugs.
To
develop their «
disease in a dish»
model, the team took skin cells from patients with Allan - Herndon - Dudley syndrome and reprogrammed them into induced pluripotent stem cells, which then can be
developed into any type
of tissue in the body.
In the present study, the researchers have discovered a reason for reduced fertility in people with autoimmune polyendocrine syndrome type 1 (APS1), which increases the risk
of developing autoimmune
disease (caused by the immune system attacking and damaging healthy cells) and which is often used as a
model for autoimmune
disease in general.
Using iPSCs, researchers
developed a novel cellular
disease model to probe the neurobiological causes
of schizophrenia, which are not well understood (ChangHui Pak, abstract 032.29, see attached summary).
The sheep
model of Huntington's
disease has been
developed to increase knowledge about Huntington's
disease.
Known as a triple transgenic
model, the animals
develop three key characteristics
of the
disease: memory impairment, amyloid plagues, and neurofibrillary tangles.
To study the pathogenesis
of HIV - induced PNS
disease, Jamie Dorsey, Research Technologist, and the research team led by Dr. Mankowski
developed a simian immunodeficiency virus (SIV)- infected macaque
model that closely reflects key peripheral nervous system (PNS) alterations seen in HIV patients with peripheral neuropathy.
With the FFI and CJD
models in hand, Jackson says he's excited to investigate how the pathology
of these
diseases develops.
When the weather - based
model developed at Rothamsted Research was used to predict how climate change may affect the wheat crops, it was predicted that wheat flowering dates will generally be earlier and the incidence
of the ear blight
disease on the wheat crops will substantially increase.
Nath's team is currently
developing an animal
model of Nodding syndrome to further study the
disease and test potential therapies.
A promising new avenue for treating hepatitis B has been reported by researchers at Hiroshima University who have
developed a new animal
model of the
disease.
Most importantly, these cells protected mice from
developing diabetes in a
model of disease, having the critical ability to produce insulin in response to changes in glucose levels.
University
of Adelaide researchers have
developed a computer simulation
model which supports the theory that sexual reproduction evolved because
of the presence
of disease - causing microbes and the need to constantly adapt to resist these co-evolving pathogens.
The researchers
developed a
model of Alzheimer's
disease and were surprised to find that increased levels
of a gene involved in the production
of toxic proteins in the brain not only led to Alzheimer's - like symptoms, but also to the development
of diabetic complications.
Now, a team
of scientists at the Icahn School
of Medicine at Mount Sinai have
developed the Just EGFP Death - Inducing T - cell, or JEDI T - cells, which enable the visualization
of T - cell antigens, allowing researchers to study T - cell interactions with different cell types,
model disease states, and finally determine the functions
of otherwise poorly characterized cell populations.
Previous
models, however, have been unable to explain why only 10 percent
of women
develop the
disease when most experience retrograde menstruation at some point.
He returned to St. Louis and shifted several members
of his lab to studying Zika, including
developing mouse
models of the
disease.
The prevalence
model,
developed by RTI for the United States Centers for
Disease Control and Prevention, illustrates some
of issues the nation will face as diabetes rates increase and Americans live longer.
The new Penn -
developed model replaces a previous
model that only examined pre-operative features such as a history
of chronic obstructive pulmonary
disease, congestive heart failure, or coronary artery
disease.
Reported today in
Disease Models & Mechanisms, Karim Si - Tayeb and colleagues in the research group of Bertrand Cariou from l'Institut du Thorax, Nantes used an innovative approach to develop unique patient cell - based models of PCSK9 - driven hypercholestero
Models & Mechanisms, Karim Si - Tayeb and colleagues in the research group
of Bertrand Cariou from l'Institut du Thorax, Nantes used an innovative approach to
develop unique patient cell - based
models of PCSK9 - driven hypercholestero
models of PCSK9 - driven hypercholesterolemia.
To test whether fatty acid levels in the bloodstream was a cause or a consequence
of disease, the researchers turned to a zebrafish
model of Crohn's
disease that had been
developed by Stefan Oehlers, a post-doctoral fellow in David Tobin's group at Duke.
Using data from the outbreak
of cholera that started in 2010 in the region, they
developed a mathematical
model of the
disease's epidemiology.
Potential outbreaks
of diseases such as Ebola and Lassa fever may be more accurately predicted thanks to a new mathematical
model developed by researchers at the University
of Cambridge.
Using a recently
developed genome - editing technique called CRISPR, a Chinese team has successfully altered two target genes in cynomolgus monkeys, paving the way for the development
of monkey
models that mimic human
diseases.
Scientists have
developed the first true animal
model of Huntington's
disease, a progressive and often fatal deterioration
of the central nervous system.
He is also
developing a robust and comprehensive panel
of 3 - D cell culture
models from patient - derived primary cells that can be used to characterize different
disease phenotypes and investigate the chemo - response
of cells to novel or known drugs.
The new finding is the latest evidence supporting a growing precision medicine
model of psychiatric
disease in which disruptions
of certain genes during brain development contribute to a person's risk for multiple psychiatric disorders, with other genetic or epigenetic drivers, random developmental events, or environmental influences determining the specific
disease an individual
develops, said senior author Benjamin Cheyette, MD, PhD, an associate professor
of psychiatry and a member
of the UCSF Weill Institute for Neurosciences and the Kavli Institute for Fundamental Neuroscience at UCSF.
However, in a few
developing countries,
model TB - control programmes supported by the International Union against Tuberculosis and Lung
Disease may be limiting the spread
of TB.
Her lab is now
developing a
model system for Parkinson's
disease that includes brain, liver, and gastrointestinal tissue, which she plans to use to investigate the hypothesis that bacteria found in the gut can influence the development
of Parkinson's
disease.
One
of the most promising avenues for
developing a cure, however, is through gene therapy, and to create those therapies requires animal
models of disease that closely replicate the human condition.
First, the researchers
developed a
model of Parkinson's in zebrafish — the first such animal
model of the
disease — and exposed them to ziram so that they lost dopamine.
The monkey
model has its own limitations: Monkeys don't
develop severe
disease when infected with different serotypes
of dengue virus, which clearly happens in humans.
Kanta Subbarao
of the National Institute
of Allergy and Infectious Diseases in Bethesda, Maryland, said her group has had to stop its efforts to adapt the MERS virus to mice to
develop an animal
model for the
disease.
Noting the potential
of gene therapy to be a one - time treatment for rare and serious
diseases that otherwise cost hundreds
of thousands, if not millions,
of dollars in chronic care over a lifetime, Stuart Orkin, MD, and co-author Philip Reilly, MD, JD,
of Third Rock Ventures, seek to «catalyze the discussion» by suggesting several new
models for valuing, pricing and
developing gene therapy.
The discovery was made by
developing a mouse
model of the
disease that enabled researchers to track which
of 15 genetic groups — or subclones —
of myeloma cells spread beyond their initial site in the animals» hind legs.
To study the still unknown pathogenesis
of the
disease, the researchers
developed a mouse
model susceptible to the full range
of infection by the human parasite.
The authors
developed a mathematical
model accounting for
disease progression, mortality, morbidity and the heterosexual transmission
of HIV to help forecast future trends in the
disease.
By tuning the
model to replicate population data, such as the number
of people at risk for
developing TB and the fraction
of TB patients who have drug resistance, the
model can predict changes in the TB
disease burden — or number
of cases — over many years.
The finding, by researchers at the University
of Illinois at Chicago College
of Medicine, was reported July 16 at the Alzheimer's Association International Conference in Copenhagen by Mary Jo LaDu, who in 2012
developed a transgenic mouse that is now regarded as the best animal
model of the human
disease.
Researchers from the Institute
of Neuroscience at the Universitat Autònoma de Barcelona have discovered the cellular mechanism involved in memory consolidation and were able to
develop a gene therapy which reverses the loss
of memory in mice
models with initial stages
of Alzheimer's
disease.
This technology has been
developed from a skin explant
model for predicting a potentially serious complication
of bone marrow transplantation, «graft versus host»
disease — a common complication following the transplant.
Prof. Jean - Christophe Marine (VIB - KU Leuven) and others
developed mouse
models recapitulating some
of the key histopathological features
of the human
disease.
«In collaboration with researchers from the University
of Calgary and the University
of British Columbia our team has
developed a computer
model to help doctors and their patients better understand how excess body weight contributes to reduced life expectancy and premature development
of heart
disease and diabetes,» says lead author Dr. Steven Grover, a Clinical Epidemiologist at the RI - MUHC and a Professor
of Medicine at McGill University.
In collaboration with the United States Department
of Agriculture (USDA), researchers in the UPV / EHU's «Nutrition and Obesity» Group, which belongs to the Spanish Biomedical Research Centre in Physiopathology
of Obesity and Nutrition (CIBERobn)
of the Carlos III Institute
of Health, have observed in animal
models that its administration reduces the build - up
of body fat, which could reduce the risk
of developing other
diseases like diabetes.
Dr. Grover and his colleagues used data from the National Health and Nutrition Examination Survey (from years 2003 to 2010) to
develop a
model that estimates the annual risk
of diabetes and cardiovascular
disease in adults with different body weights.